WHO suspended hydroxychloroquine trials in treatment of COVID-19

US, WASHINGTON (ORDO NEWS) — The World Health Organization (WHO) has suspended trials of hydroxychloroquine and chloroquine as a cure for coronavirus-induced COVID-19 disease. This was announced on May 25 at a briefing by the Director-General of WHO, Tedros Adan Gebreyesus.

“The executive group has temporarily suspended the use of hydroxychloroquine and chloroquine as part of a solidarity test,” the organization said on a Twitter page.

As the WHO Director General reminded, on May 22, The Lancet published an article on the test of hydroxychloroquine and chloroquine against COVID-19, which stated that when using these drugs or mixtures with them, patients died more often.

WHO then convened an expert group from 10 countries. Specialists will analyze all the data, and the organization will review the effectiveness of the drug, he explained to Gebreyesus.

According to the head of WHO, these drugs are still considered safe for patients with autoimmune diseases and malaria.

As the WHO emphasized on May 20 , the efficacy of the antimalarial drug chloroquine for the prevention and treatment of COVID-19 has not been proven. On May 19, President of the United States Donald Trump admitted daily intake as a prophylaxis of hydroxychloroquine coronavirus. In March, the United States approved the use of drugs to treat infection.

“Hydroxychloroquine” is an antimalarial drug that causes the death of erythrocyte forms of all types of plasmodium. It has immunosuppressive and some anti-inflammatory activity.


Contact us: [email protected]

Our Standards, Terms of Use: Standard Terms And Conditions.